nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—ADRB1—stomach cancer	0.514	0.543	CbGaD
Bupranolol—ADRB2—stomach cancer	0.433	0.457	CbGaD
Bupranolol—Pirbuterol—ADRB1—stomach cancer	0.000691	0.0634	CrCbGaD
Bupranolol—Levobunolol—ADRB1—stomach cancer	0.000616	0.0565	CrCbGaD
Bupranolol—Timolol—ADRB1—stomach cancer	0.000587	0.0539	CrCbGaD
Bupranolol—Pirbuterol—ADRB2—stomach cancer	0.000581	0.0533	CrCbGaD
Bupranolol—Carteolol—ADRB1—stomach cancer	0.000524	0.0481	CrCbGaD
Bupranolol—Levobunolol—ADRB2—stomach cancer	0.000518	0.0475	CrCbGaD
Bupranolol—Timolol—ADRB2—stomach cancer	0.000494	0.0453	CrCbGaD
Bupranolol—Terbutaline—ADRB2—stomach cancer	0.000474	0.0435	CrCbGaD
Bupranolol—Nadolol—ADRB1—stomach cancer	0.000467	0.0428	CrCbGaD
Bupranolol—Clenbuterol—ADRB1—stomach cancer	0.00045	0.0413	CrCbGaD
Bupranolol—Carteolol—ADRB2—stomach cancer	0.00044	0.0404	CrCbGaD
Bupranolol—Clenbuterol—TNF—stomach cancer	0.000427	0.0392	CrCbGaD
Bupranolol—Bopindolol—ADRB1—stomach cancer	0.000427	0.0392	CrCbGaD
Bupranolol—Salbutamol—ADRB1—stomach cancer	0.000419	0.0384	CrCbGaD
Bupranolol—Penbutolol—ADRB1—stomach cancer	0.000407	0.0374	CrCbGaD
Bupranolol—Nadolol—ADRB2—stomach cancer	0.000392	0.036	CrCbGaD
Bupranolol—Bopindolol—HTR1A—stomach cancer	0.000382	0.0351	CrCbGaD
Bupranolol—Clenbuterol—ADRB2—stomach cancer	0.000379	0.0348	CrCbGaD
Bupranolol—Penbutolol—HTR1A—stomach cancer	0.000364	0.0334	CrCbGaD
Bupranolol—Bopindolol—ADRB2—stomach cancer	0.000359	0.0329	CrCbGaD
Bupranolol—Salbutamol—ADRB2—stomach cancer	0.000352	0.0323	CrCbGaD
Bupranolol—Penbutolol—ADRB2—stomach cancer	0.000342	0.0314	CrCbGaD
Bupranolol—Pindolol—ADRB1—stomach cancer	0.000293	0.0269	CrCbGaD
Bupranolol—Pindolol—HTR1A—stomach cancer	0.000263	0.0241	CrCbGaD
Bupranolol—Pindolol—ADRB2—stomach cancer	0.000247	0.0227	CrCbGaD
Bupranolol—ADRB1—Signaling Pathways—GLI3—stomach cancer	5.33e-05	0.00127	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KISS1R—stomach cancer	5.21e-05	0.00124	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GLI3—stomach cancer	5.21e-05	0.00124	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FST—stomach cancer	5.15e-05	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADRB2—stomach cancer	5.13e-05	0.00122	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RBP1—stomach cancer	5.08e-05	0.00121	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HBEGF—stomach cancer	5.04e-05	0.0012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GAST—stomach cancer	5e-05	0.00119	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RGS2—stomach cancer	5e-05	0.00119	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GAST—stomach cancer	4.97e-05	0.00118	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RGS2—stomach cancer	4.97e-05	0.00118	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RBP1—stomach cancer	4.97e-05	0.00118	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RGS2—stomach cancer	4.89e-05	0.00116	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GAST—stomach cancer	4.89e-05	0.00116	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGG—stomach cancer	4.71e-05	0.00112	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRB2—stomach cancer	4.65e-05	0.00111	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PPP2R1A—stomach cancer	4.56e-05	0.00109	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKAA1—stomach cancer	4.54e-05	0.00108	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RBP4—stomach cancer	4.38e-05	0.00104	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL8—stomach cancer	4.38e-05	0.00104	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AGTR2—stomach cancer	4.17e-05	0.000992	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—WWOX—stomach cancer	4.14e-05	0.000986	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—F2R—stomach cancer	4.12e-05	0.000981	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AGTR2—stomach cancer	4.08e-05	0.000971	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—WWOX—stomach cancer	4.05e-05	0.000964	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—F2R—stomach cancer	4.03e-05	0.00096	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR1A—stomach cancer	4.01e-05	0.000955	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR1A—stomach cancer	3.93e-05	0.000935	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ANXA1—stomach cancer	3.88e-05	0.000923	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HRH4—stomach cancer	3.85e-05	0.000917	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—WIF1—stomach cancer	3.85e-05	0.000917	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ANXA1—stomach cancer	3.79e-05	0.000903	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AGTR2—stomach cancer	3.79e-05	0.000901	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HSPB1—stomach cancer	3.77e-05	0.000897	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AGTR2—stomach cancer	3.77e-05	0.000897	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—WIF1—stomach cancer	3.77e-05	0.000897	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HRH4—stomach cancer	3.77e-05	0.000897	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—F2R—stomach cancer	3.74e-05	0.000891	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—BMP2—stomach cancer	3.73e-05	0.000887	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—F2R—stomach cancer	3.73e-05	0.000887	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	3.7e-05	0.000882	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	3.67e-05	0.000874	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKR1C3—stomach cancer	3.67e-05	0.000873	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—F2R—stomach cancer	3.66e-05	0.000872	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	3.65e-05	0.000868	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR1A—stomach cancer	3.63e-05	0.000863	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	3.57e-05	0.000849	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	3.55e-05	0.000846	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	3.52e-05	0.000838	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PRKCB—stomach cancer	3.51e-05	0.000836	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ANXA1—stomach cancer	3.5e-05	0.000834	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	3.48e-05	0.000827	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	3.44e-05	0.00082	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	3.43e-05	0.000817	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	3.43e-05	0.000817	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	3.41e-05	0.000813	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRB1—stomach cancer	3.39e-05	0.000808	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	3.36e-05	0.000799	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	3.36e-05	0.000799	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	3.34e-05	0.000795	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	3.34e-05	0.000794	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RPS6—stomach cancer	3.24e-05	0.000772	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PRKCB—stomach cancer	3.19e-05	0.000759	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6ST—stomach cancer	3.18e-05	0.000756	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FST—stomach cancer	3.06e-05	0.000728	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	3.04e-05	0.000724	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	2.99e-05	0.000712	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FST—stomach cancer	2.99e-05	0.000712	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HBEGF—stomach cancer	2.98e-05	0.000709	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	2.95e-05	0.000702	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GAST—stomach cancer	2.95e-05	0.000702	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	2.93e-05	0.000697	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GAST—stomach cancer	2.89e-05	0.000687	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	2.89e-05	0.000687	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6R—stomach cancer	2.83e-05	0.000675	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—RHOA—stomach cancer	2.82e-05	0.000671	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGG—stomach cancer	2.8e-05	0.000666	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	2.76e-05	0.000657	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRB2—stomach cancer	2.75e-05	0.000654	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGG—stomach cancer	2.74e-05	0.000651	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	2.71e-05	0.000644	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PPP2R1A—stomach cancer	2.69e-05	0.000641	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	2.69e-05	0.000641	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	2.65e-05	0.00063	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	2.63e-05	0.000627	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	2.6e-05	0.000619	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	2.6e-05	0.000619	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—RHOA—stomach cancer	2.56e-05	0.000609	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	2.54e-05	0.000606	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	2.54e-05	0.000605	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SMAD4—stomach cancer	2.5e-05	0.000595	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL8—stomach cancer	2.48e-05	0.000589	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FYN—stomach cancer	2.38e-05	0.000565	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL8—stomach cancer	2.25e-05	0.000535	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	2.24e-05	0.000532	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	2.24e-05	0.000532	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGFR2—stomach cancer	2.23e-05	0.000531	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	2.21e-05	0.000526	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—F2R—stomach cancer	2.21e-05	0.000526	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	2.19e-05	0.000521	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	2.19e-05	0.000521	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	2.18e-05	0.000518	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	2.16e-05	0.000515	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—F2R—stomach cancer	2.16e-05	0.000515	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	2.15e-05	0.000512	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	2.13e-05	0.000507	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	2.11e-05	0.000501	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	2.08e-05	0.000496	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	2.08e-05	0.000495	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IRS2—stomach cancer	2.04e-05	0.000486	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	2.04e-05	0.000485	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	2.03e-05	0.000484	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CAV1—stomach cancer	1.98e-05	0.000471	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOA1—stomach cancer	1.98e-05	0.00047	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	1.97e-05	0.000469	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	1.92e-05	0.000458	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	1.89e-05	0.000451	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	1.89e-05	0.000449	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKCB—stomach cancer	1.88e-05	0.000448	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	1.88e-05	0.000448	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6ST—stomach cancer	1.88e-05	0.000447	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	1.85e-05	0.000441	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	1.84e-05	0.000439	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APC—stomach cancer	1.8e-05	0.000429	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	1.77e-05	0.000421	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	1.73e-05	0.000412	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK3—stomach cancer	1.73e-05	0.000411	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	1.68e-05	0.0004	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6R—stomach cancer	1.67e-05	0.000399	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	1.67e-05	0.000398	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	1.65e-05	0.000392	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK1—stomach cancer	1.64e-05	0.000391	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EGFR—stomach cancer	1.64e-05	0.000391	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	1.64e-05	0.00039	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	1.63e-05	0.000388	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	1.6e-05	0.000381	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PIK3CA—stomach cancer	1.57e-05	0.000374	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SERPINE1—stomach cancer	1.57e-05	0.000373	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	1.56e-05	0.000372	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—KRAS—stomach cancer	1.55e-05	0.000369	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	1.52e-05	0.000362	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RHOA—stomach cancer	1.51e-05	0.00036	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOS3—stomach cancer	1.5e-05	0.000356	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	1.49e-05	0.000354	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	1.48e-05	0.000353	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	1.47e-05	0.00035	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	1.45e-05	0.000346	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	1.44e-05	0.000342	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PIK3CA—stomach cancer	1.43e-05	0.000339	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FYN—stomach cancer	1.41e-05	0.000336	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ERBB2—stomach cancer	1.4e-05	0.000333	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FYN—stomach cancer	1.38e-05	0.000328	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	1.33e-05	0.000318	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—stomach cancer	1.33e-05	0.000316	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	1.32e-05	0.000315	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HRAS—stomach cancer	1.32e-05	0.000314	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	1.31e-05	0.000311	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDKN1B—stomach cancer	1.3e-05	0.000309	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	1.29e-05	0.000308	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—stomach cancer	1.26e-05	0.000301	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCND1—stomach cancer	1.24e-05	0.000294	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—JUN—stomach cancer	1.23e-05	0.000294	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	1.21e-05	0.000288	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—stomach cancer	1.2e-05	0.000286	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDKN1A—stomach cancer	1.2e-05	0.000285	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	1.19e-05	0.000282	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	1.18e-05	0.00028	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	1.17e-05	0.000279	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK8—stomach cancer	1.17e-05	0.000278	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	1.15e-05	0.000274	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	1.15e-05	0.000273	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	1.12e-05	0.000266	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	1.11e-05	0.000265	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	1.09e-05	0.00026	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	1.09e-05	0.000259	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—stomach cancer	1.08e-05	0.000257	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APC—stomach cancer	1.07e-05	0.000255	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—STAT3—stomach cancer	1.07e-05	0.000254	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APC—stomach cancer	1.05e-05	0.000249	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	1.03e-05	0.000244	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK3—stomach cancer	1.02e-05	0.000243	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	1e-05	0.000239	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	9.94e-06	0.000237	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MYC—stomach cancer	9.92e-06	0.000236	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	9.75e-06	0.000232	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	9.75e-06	0.000232	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	9.72e-06	0.000231	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK1—stomach cancer	9.71e-06	0.000231	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EGFR—stomach cancer	9.71e-06	0.000231	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	9.54e-06	0.000227	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	9.54e-06	0.000227	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	9.32e-06	0.000222	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	9.31e-06	0.000221	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	9.21e-06	0.000219	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KRAS—stomach cancer	9.17e-06	0.000218	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	9.12e-06	0.000217	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	9.1e-06	0.000217	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	9.01e-06	0.000214	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	8.98e-06	0.000214	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	8.89e-06	0.000211	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	8.78e-06	0.000209	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	8.69e-06	0.000207	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	8.46e-06	0.000201	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CA—stomach cancer	8.42e-06	0.0002	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	8.31e-06	0.000198	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	8.28e-06	0.000197	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TP53—stomach cancer	8.15e-06	0.000194	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	8.13e-06	0.000193	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	7.88e-06	0.000188	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	7.83e-06	0.000186	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HRAS—stomach cancer	7.79e-06	0.000185	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	7.71e-06	0.000183	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	7.7e-06	0.000183	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	7.66e-06	0.000182	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	7.53e-06	0.000179	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	7.49e-06	0.000178	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—stomach cancer	7.46e-06	0.000178	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	7.34e-06	0.000175	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	7.33e-06	0.000174	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JUN—stomach cancer	7.33e-06	0.000174	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	7.18e-06	0.000171	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JUN—stomach cancer	7.17e-06	0.000171	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	7.13e-06	0.00017	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	7.1e-06	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	6.97e-06	0.000166	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	6.95e-06	0.000165	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	6.93e-06	0.000165	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	6.78e-06	0.000161	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	6.4e-06	0.000152	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	6.34e-06	0.000151	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	6.26e-06	0.000149	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	6.2e-06	0.000148	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	6.06e-06	0.000144	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	5.92e-06	0.000141	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MYC—stomach cancer	5.89e-06	0.00014	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	5.76e-06	0.000137	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MYC—stomach cancer	5.76e-06	0.000137	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	5.76e-06	0.000137	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	5.64e-06	0.000134	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	5.64e-06	0.000134	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	5.44e-06	0.00013	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	5.32e-06	0.000127	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	5e-06	0.000119	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	4.89e-06	0.000116	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TP53—stomach cancer	4.84e-06	0.000115	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TP53—stomach cancer	4.73e-06	0.000113	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	4.63e-06	0.00011	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	4.52e-06	0.000108	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—stomach cancer	4.43e-06	0.000105	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—stomach cancer	4.33e-06	0.000103	CbGpPWpGaD
